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Obtaining a suitable experimental cellular model is a 
major problem for neuroscience studies. Neuroblasto-
ma cell lines have been often applied in studies relat-
ed to pathological disorders of nervous system. How-
ever, in the search for an ideal model, these cells must 
be differentiated to cancel their tumor character. The 
subsequent reactions that are caused by differentiation 
are not always indifferent to the same model. We eval-
uated the effect of two well known substances, used for 
SH-N-SK cell line differentiation, retinoic acid (RA) and 
phorbol-12-myristate-13-acetate (PMA), on the induc-
tion of pro-inflammatory and pro-oxidative reactions in 
these cells. Cells differentiated with PMA were able to 
produce significantly higher amounts of pro-inflammato-
ry cytokines whereas the release of nitric oxide radicals 
was similar to that in undifferentiated cells. On the con-
trary, in RA-differentiated cells no significant changes in 
cytokine production were observed and the nitric oxide 
release was decreased. Additionally, the RA-differentiat-
ed neuronal model was more sensible to lipopolysaccha-
ride stimulation, producing pro-inflammatory cytokines 
abundantly. These results suggest that RA-differentiat-
ed SH-N-SK cells provide a more suitable experimental 
model for the study of molecular and cellular mecha-
nisms of the inflammation and oxidative stress in neuro-
nal cells.
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INTRODUCTION
Many neurological processes are frequently investi-
gated using isolated primary cells of animals. However, 
primary cultures are difficult to maintain, relatively short-
lived and sometimes the isolation procedure is compli-
cated. Moreover, some studies may require sacrificing 
large numbers of animals. Because living and mature 
human neurons are not readily available, various cell 
lines, usually various types of neuroblastoma, can be 
an alternative for neuroscience research. An immortal-
ized cell line, most frequently used for those purposes 
is the human neuroblastoma SK-N-SH line that was 
derived from malignant cells of a bone marrow biopsy 
taken from a four year-old female neuroblastoma pa-
tient. These cells are of neurogenic origin, as evidenced 
by the high dopamine-b-hydroxylase activity, an enzyme 
found exclusively in nervous tissues (Biedler et al., 1973). 
The SK-N-SH cell line is relatively homogeneous and 
comprises two types of cells, a small neuroblastic type 
and a flat epithelial one. Nevertheless, the use of this 
cell line as a tumour model allowed to explore numer-
ous processes related to cancer therapy. However, during 
development of the stable line of these cells, arrested at 
an early, immature stage, they retained the ability to dif-
ferentiate, under appropriate conditions, into neuron-like 
cells, thus providing a popular human neuronal model. 
Cell differentiation is often accompanied by the inhibi-
tion of certain cellular processes, such as proliferation 
and migration, and also by changes in cell morphology, 
such as the growth and elongation of neurites. Several 
neuroblastoma cell lines, together with SK-N-SH cells, 
were induced to differentiate with diverse agents, includ-
ing retinoic acid (RA), phorbol-12-myristate-13-acetate 
(PMA), brain-derived neurotrophic factor (BDNF) or 
nerve growth factor (Thiele, 1998). However, the use of 
some of the differentiating agents can lead to adverse 
reactions, producing a model of mature neuronal cells, 
which may possess a basal state unsuitable for further 
studies. Indeed, apoptotic effects of interferon-γ or RA 
on some neuroblastoma cell lines were reported (Thiele, 
1998). On the other hand, some changes in mitochon-
drial functions in PMA-differentiated human leukemia 
cell line K652 were also registered (Huang et al., 2014). 
Thereby, the preparation of a suitable cellular model, ob-
tained through cell differentiation, requires rigorous ex-
aminations in order to exclude possible interference in 
the research to be performed.
In recent years, an increasing number of studies re-
ported participation of chronic inflammation and oxi-
dative stress in the development of neurodegenerative 
diseases (Khandelwal et al., 2011; Ju et al., 2014; Khalil 
et al., 2015). Human neuroblastoma cell line SK-N-SH 
is a neuronal model commonly used in studies of neu-
ronal pathologies, including neurodegenerative disorders 
(Ajjimaporn et al., 2007, Jayaraj et al., 2013). However, 
relatively little is known about a potential development 
of inflammatory and oxidative responses in undifferenti-
ated cells under the influence of differentiating agents. 
Neurodegenerative diseases are a global problem of the 
worldwide health, affecting not only the population of 
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developing countries but also the countries with a well 
developed economy. Nowadays, there is a growing inter-
est on genome and proteome research related to these 
disorders, especially concerning the pathogenesis and 
development of Parkinson’s and Alzheimer’s diseases. 
Therefore, the selection of an adequate model for ex-
periments in vitro, relating to inflammatory and oxida-
tive processes involved in neurodegeneration would be 
helpful. In our current study, we evaluated two of the 
most known substances used for cell differentiation — 
RA and PMA - in terms of their ability to triggering the 
inflammatory response and oxidative stress in SK-N-SH 
cells. We also analyzed the response of these cells, af-
ter differentiation, to a potent pro-inflammatory factor, 
lipopolisacharide (LPS). At the same time, morphologi-
cal and biochemical changes related to cell differentia-
tion were examined. Our results suggest that SH-N-SK 
cells differentiated for 6 days with 5 µM RA represent 
the more suitable experimental model for studying the 
molecular and cellular mechanisms underlying the patho-
physiology of inflammation and oxidative stress in neu-
ronal cells.
MATERIALS AND METHODS
Chemicals. 2,3-Diaminonaphtalene (DAN), phorbol 
12-myristate 13-acetate (PMA), protease inhibitor cock-
tail, retinoid acid (RA), TRI-reagent and other stand-
ard chemicals were supplied by Sigma (USA). Antibiot-
ics, antimycotics, cell culture media, fetal bovine serum 
(FBS), non-essential amino acids and sodium pyruvate 
were purchased from Thermo Fisher Scientific (USA).
Cell culture. The human neuroblastoma cell line SK-
N-SH supplied by ATCC (USA) was cultured in MEM 
medium supplemented with 1% non-essential amino ac-
ids, 1 mM sodium pyruvate, 10% FBS and a mixture of 
antibiotics and antimycotics (1 U/ml penicillin, 1 µg/ml 
streptomycin and 2.5 μg/ml amphotericin B) in a hu-
midified atmosphere containing 5% CO2 at 37°C.
Cell differentiation. The neuronal phenotype of SK-
N-SH cells was induced by cell incubation in 1% FBS 
cell culture medium, alone and supplemented with 5 µM 
RA or 25 nM PMA for 6 days with medium change eve-
ry three days. Cells were also treated with both agents (3 
days with 5 mM RA and 3 days with 25 nM PMA). The 
cells cultured in 10% MEM were considered as undiffer-
entiated, and these cultured only in 1% MEM (low FBS 
medium) served as a control against differentiated cells.
The most commonly measured characteristics of dif-
ferentiation for neuroblastoma cells is the neurite ex-
tension. In order to monitor those changes, cells were 
photographed in an inverted phase contrast microscope 
Nikon Eclipse TS100 (Japan) equipped with ToupCam 
Industrial Digital Camera TP605100A (China) before 
stimulation and after 3 and 6 days of the treatment. The 
differentiation index, calculated as the ratio of the den-
drite length to the cell diameter, was determined from 
the cell microscopic images (20× magnification). Meas-
urements were performed in at least 50 cells within ran-
domly chosen fields, using the ImageJ Software.
Cell proliferation. The proliferation level was ana-
lyzed with an immunoenzymatic test, BrdU Cell Pro-
liferation Assay kit (Calbiochem, USA). SK-N-SH cells 
(6×103) were differentiated as mentioned above and on 
the last day of treatment with differentiating agents a 
BrdU solution (1:2000) was added for further 24 hours. 
After that, the BrdU assay was performed according to 
the manufacturer’s instructions. The results were pre-
sented as a percentage of BrdU incorporation into cells 
after differentiation in comparison to undifferentiated 
cells, the latter assumed represent 100%. Additionally, 
total protein concentration in lysates of differentiated 
and undifferentiated cells was assayed with Lowry meth-
od (Lowry et al., 1951).
Caspase activity measurement. Caspase 3/7 activ-
ity was assayed with a chemiluminescent method using 
Caspase-Glo® 3/7 Assay from Promega (USA). Cells 
(6×103) were differentiated in 96-well microplate as men-
tioned above, and the enzyme activity was measured ac-
cording to the manufacturer’s instructions. Changes in 
chemiluminescence were analyzed in a microplate reader 
Synergy H1 from BioTek Instruments (USA). The re-
sults were described as the relative enzymatic activity of 
differentiated cells compared to that of undifferentiated 
cells.
Gene expression analysis. SK-N-SH cells were dif-
ferentiated using RA or RA/PMA as described above. 
For gene expression analysis, the total RNA of undif-
ferentiated and differentiated cells was isolated with 
TRI-Reagent. Changes of mRNA expression for BDNF, 
c-myc, interleukin 1β (IL-1β), interleukin 6 (IL-6), neu-
rospecific nuclear marker (NeuN) and tumor necrosis 
factor α (TNF-α) were analyzed with a two-step RT-
PCR procedure. The amount of elongation factor 2 (EF-
2) mRNA was also determined in each sample for the 
subsequent quantitative analysis. The cDNA synthesized 
with M-MLV Reverse Transcriptase kit (Promega, USA), 
was amplified with Real-time PCR procedure using the 
SYBR Green kit (Kappa Biosystem, USA) in a Ther-
mocycler 7500 Fast Real-Time PCR System (Life Tech-
nologies, USA). Specific primers (at final concentration 
of 10 μM) were used for PCR reaction. The primer pair 
sequences for the studied genes are specified in Table 1. 
The annealing temperature for specific primers during 
PCR reaction was 58°C for c-myc, EF-2 and NeuN, 60°C 
for BDNF and IL-6 and 62°C for IL-1β and TNF-α. The 
thermal cycler conditions were: 95°C for 10 min, fol-
lowed by 95°C for 15 s, 15 s at the corresponding an-
nealing temperature and 72°C for 30 s (40 cycles). Data 
analysis was undertaken applying a ΔCt method using a 
housekeeping gene expression (EF-2) and the 7500 Fast 
Real-Time PCR Software.
Measurement of nitrite production. A fluorometric 
assay (Misko et al., 1993) was used to check the influ-
ence of differentiating agents on the production of nitric 
oxide (NO) radicals, measured as nitrite ions. SK-N-SH 
cells (4×105) were seeded on 12-well microplate, differ-
entiated and then stimulated for 2 hours with 10 µg/ml 
TNF-α. After treatment, 100 µl of cell supernatants were 
mixed with 10 µl 320 mM DAN in 96-well microplate 
and incubated for 30 minutes at room temperature, pro-
tected from light. The reaction was stopped by the addi-
tion of 5 µl 2,8 M NaOH and the emitted fluorescence 
was measured with the Synergy H1 reader at λex = 365 
nm and λem = 440 nm.
Measurement of cytokine release. Cytokine con-
centration in cell supernatants was measured with ELI-
SA kits (IL-1β, IL-6 and TNF-α) from BD Biosciences 
(USA). Briefly, SK-N-SH cells (5×105) were seeded on 
12-well plate and, after differentiation, stimulated for 18 
hours with 100 ng/ml LPS in the presence of protease 
inhibitors. Control samples before differentiation, and af-
ter differentiation but without LPS stimulation, were also 
prepared. The released cytokines were assayed according 
to the manufacturer’s instructions. Changes in absorb-
ance were measured at 450 nm wavelength in Power-
Wave microplate reader (BioTek Instruments, USA).
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Statistical analysis. All values were presented as 
means ± standard deviation from at least three experi-
ments and the statistical significance was analyzed by 
Student’s t-test.
RESULTS
Morphological changes of the neuroblastoma cell line 
SK-N-SH after differentiation
Three models of SK-N-SH cell differentiation were 
analyzed in low FBS medium (1%) with: i) RA, ii) PMA 
and iii) a combination of RA and PMA (RA/PMA). Re-
sults were compared to undifferentiated cells, grown in 
10% FBS medium. Control samples with medium for dif-
ferentiation (1% FBS MEM) were also 
performed. Changes in cell morphol-
ogy were observed in every model after 
just 3 days (not shown). However, they 
were more evident after 6-day treatment. 
Each type of differentiation caused the 
presence of elongated dendrites in cells 
(Fig. 1D-F), whereas undifferentiated 
cells proliferated abundantly and did not 
show any morphological changes (Fig. 
1A, 1B). Dendrite growth varied de-
pending on the differentiation method. 
The shortest dendrites were observed in 
the cells cultured in low FBS medium 
(Fig. 1C), whereas the cells treated with 
RA and with the combination of RA/
PMA presented the longest dendrites (Fig. 1D and 1F, 
respectively). The cells differentiated with PMA only 
showed a relatively high growth of neurites and, addi-
tionally, in these samples the amount of cells seems to 
be lower (Fig. 1E). Those observations are in accord-
ance with the calculated differentiation index for each 
type of treatment (Fig. 1G). Similar values were obtained 
for samples with RA, PMA and both RA/PMA, with a 
6-fold increase, after 3 days of differentiation treatment, 
whereas for the cells treated only with 1% MEM the dif-
ferentiation index was definitely lower. After 6-day treat-
ment, the highest values were noticed only for samples 
with RA and RA/PMA (5-6-fold relatively to undiffer-
entiated cells, that did not present significant changes in 
their morphology during this incubation time).
Table 1. Primers sequences used for gene amplification.








Figure 1. Analysis of the morphological changes of SK-N-SH cells after differentiation. 
Morphology of SK-N-SH cells (3×104) before (A) and after 6-day treatment with 10% FBS MEM (B), 1% MEM (C), 5 μM RA (D), 25 nM PMA 
(E) and 3-day treatment with 5 μM RA followed by 3-day incubation with 25 nM PMA (F). Cell differentiation level was presented as the 
differentiation index, which was calculated as the ratio of dendrite length to cell diameter (G). *P<0.01 versus undifferentiated cells (con-
trol sample) after 3 days, **P< 0.01 versus undifferentiated cells after 6 days.
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Cell proliferation of the neuroblastoma cell line SK-N-
SH after differentiation
The inhibition of cell proliferation is commonly 
known as the main indicative of cell differentiation. To 
determine the influence of differentiating agents on cell 
proliferation, undifferentiated and differentiated SK-N-
SH cells were checked for BrdU incorporation during 
24 h incubation. The amount of incorporated BrdU into 
cells varied depending on cell treatment. The BrdU con-
tent was similar in cells differentiated by RA and RA/
PMA (about 40%), whereas treatment with PMA and 
low FBS medium resulted in 55% and 77% incorpora-
tion of BrdU, respectively, suggesting a worse differentia-
tion of neuroblastoma into neuronal type cells (Fig. 2A). 
On the other hand, the analysis of the total protein con-
centration showed comparable outcomes (Fig. 2B). The 
highest protein concentration was obtained for samples 
from undifferentiated cells (4.48 mg/ml) and cells cul-
tured in 1% MEM (2.07 mg/ml), while the lowest values 
were observed in samples from cells differentiated with 
PMA (0.45 mg/ml). Similar amount of total protein was 
measured in samples with cells differentiated by using 
RA and RA/PMA (0.90 mg/ml).
The effect of differentiation on the neuroblastoma cell 
line SK-N-SH apoptosis
The influence of the differentiating agents on SK-N-
SH cell apoptosis was analyzed by measuring the cas-
pase 3/7 activity in cells. Increased enzyme activity was 
observed in samples treated with PMA, both alone or 
in combination with RA (Fig. 3). In the first case, the 
percentage of the relative caspase activity reached 280% 
as compared to undifferentiated cells, whereas RA/PMA 
enhanced cell apoptosis by 55%. No significant differ-
ences were observed between undifferentiated cells and 
cells treated only with RA or 1% MEM.
Figure 2. Proliferation of SK-N-SH cells after differentiation.
Cells were grown in 10% MEM, 1% MEM, 5 µM RA, 25 nM PMA or 
5 µM RA/25 nM PMA for 6 days. Cell proliferation was analyzed by 
BrdU assay (A) and by measurement of total protein concentra-
tion using Lowry method (B). *P<0.05 vs. undifferentiated cells in 
10% FBS MEM. **P<0.05 vs. cell cultured in 25 nM PMA.
Figure 3. Relative activity of caspase 3/7 in SK-N-SH cells after 
differentiation. 
Cells (6×103) were grown in 10% MEM, 1% MEM, 5 µM RA, 25 nM 
PMA or 5 µM RA/25 nM PMA for 6 days. The caspase 3/7 activity 
was measured with CaspoGlo3 kit and the values obtained are 
presented as the percentage of changes in chemiluminescence 
signal in samples as compared to control sample (undifferentiated 
cells), that was assumed to be 100 %. *P<0.05 vs. control cells.
Figure 4. Expression of tumor and neuronal markers after differ-
entiation of SK-N-SH cell line. 
Cells (1×106) were grown in 10% MEM, or differentiated in 1% 
MEM with 5 µM RA or 5 µM RA/25 nM PMA for 6 days. The ex-
pression for c-myc (A), BDNF (B) and NeuN (C) was analyzed by 
Real-Time PCR. *P<0.01 vs. control sample (undifferentiated cells), 
**P<0.05 vs. RA/PMA sample.
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Expression of tumor and neuronal markers after 
differentiation of the neuroblastoma cell line SK-N-SH
Gene expression for tumor (c-myc) and neuronal 
(BDNF and NeuN) markers was analyzed to describe the 
differentiation level of SK-N-SH cells. Real-Time PCR 
results indicated a significant decrease of c-myc mRNA 
after differentiation (Fig. 4A). Major changes in onco-
gene expression were observed after cell differentiation 
with both RA and RA/PMA, but RA treatment for 6 
days caused more accentuated inhibition of c-myc expres-
sion than the RA/PMA model. In the case of neuronal 
markers (Fig. 4B and 4C), both differentiation types 
resulted in enhanced mRNA expression of BDNF and 
NeuN, with similar results to these obtained for the c-
myc gene. Major effects were observed in cells treated 
with RA alone.
Proinflammatory changes after SK-N-SH cell 
differentiation
Inflammation markers after differentiation of SK-N-
SH cells were investigated both at gene expression and 
Figure 5. Expression of pro-inflammatory cytokines in SK-N-SH cells after differentiation. 
Cells after 80% confluence were grown in 10% MEM or differentiated in 1% MEM with 5 µM RA or 5 µM RA/25 nM PMA for 6 days. The 
mRNA expression and protein production for TNF-α (A, B), IL-1β (C, D) and IL-6 (E, F) were analyzed by Real-Time PCR and ELISA, respec-
tively. *P<0.05 versus control sample (undifferentiated cells).
Figure 6. Cytokine production by RA- and RA/PMA-differentiat-
ed cells after LPS stimulation. 
Cells after 80% confluence were differentiated with 5 µM RA or 5 
µM RA/25 nM PMA for 6 days and then stimulated with 100 ng/
ml LPS for 18 h. LPS-induced cytokine production, measured by 
ELISA, was presented as the percentage of cytokine release after 
stimulation in comparison to non-stimulated differentiated cells, 
assumed to be 100%. **P<0.05 versus RA/PMA-differentiated cells.
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protein production levels. The change in the mRNA 
expression of cytokines (IL-1β, IL-6 and TNF-α) af-
ter differentiation was presented in Fig. 5. Cells treated 
with RA in combination with PMA showed more sig-
nificant mRNA expression of all of the studied cytokines 
(Fig. 5A, 5C and 5E). The RA treatment also caused an 
augmentation of the amount of cytokine mRNA; howev-
er, this increase was definitively lower than in the case of 
RA/PMA treatment. Those observations were compared 
with the cytokine release into culture medium assayed 
with ELISA test. The results corroborated the observed 
trend in the expression of cytokine mRNA, but only in 
the case of cells treated with RA/PMA. The level of 
all studied cytokines was significantly higher (by 363%, 
243% and 118%, respectively for TNF-α, IL-1β, and IL-
6), whereas in cells treated with RA alone their concen-
tration was similar to that observed in undifferentiated 
cells. Only IL-1β concentration was slightly increased 
but any statistical significance was observed as compare 
with untreated cells (Fig 5B, 5D, 5F).
Due to significant changes in cytokine production in 
the neuron-like cell models studied, LPS stimulation al-
lowed to assess their sensibility to pro-inflammatory 
agents. The percentage of the LPS-induced cytokine pro-
duction by these cell models varied significantly (Fig. 6). 
RA-differentiated cells produced more cytokines in re-
sponse to LPS stimulation than cells treated with RA/
PMA. The production of TNF-α, after LPS stimulation 
of RA-treated cells was twice higher than in the RA/
PMA model. Similar results were observed for IL-1β 
and IL-6 production by RA-differentiated cells after LPS 
stimulation, indicating a higher cytokine release than that 
obtained with cells differentiated with RA/PMA, i.e., 
211% and 199%, respectively.
Effect of SK-N-SH cell differentiation on NO production
Since activation of pro-inflammatory response is often 
associated with stimulation of pro-oxidative processes, in 
this study we also analyzed the influence of differenti-
ating agents on the modulation of an oxidative marker, 
the level of NO radicals. In this regard, the amount of 
nitrite ions, produced by undifferentiated cells and by 
cells treated with RA or RA/PMA, was measured. Re-
sults obtained by fluorometric assay showed a lower NO 
production by RA-differentiated cells in comparison to 
cells treated with RA/PMA, for which NO concentra-
tion turned out to be similar to that by the undifferenti-
ated cells (Fig. 7A). Moreover, an analogous study as in 
the case of pro-inflammatory cytokines was conducted 
to check the difference between the two cell models to 
produce NO after TNF-α stimulation. The effect of cy-
tokine stimulation was less significant than that obtained 
in the case of cytokine release; however, RA-differenti-
ated cells presented a major sensibility to produce NO 
than cells treated with RA/PMA (Fig. 7B).
DISCUSSION
Several studies reported the in vitro differentiation of 
the SK-N-SH cell line using various agents that promote 
coordinated biochemical, morphological and ultrastruc-
tural changes leading to neuronal phenotypes (Pahlman et 
al., 1995; Thiele, 1998). SK-N-SH cell line is composed 
of two types of cells, a small spiny cell (neuronal type) 
and a large epithelioid cell type (Biedler et al., 1973). Nu-
merous studies reported that, depending on the type of 
differentiating agents, distinct phenotypes of cells can be 
obtained. These observations implicate rigorous evalua-
tion of the influence of these agents on cellular signalling 
pathways, which can be of primordial importance for the 
selection of an appropriate model for neuroscience. In 
our studies we checked the influence of the main differ-
entiating factors like RA and PMA on pro-inflammatory 
and pro-oxidative changes in the widely used SK-N-SH 
cell line, looking for a reliable cell model of neurode-
generative disease, in which biochemical and molecular 
changes could be examined during cell degeneration. As 
expected, our results confirmed the ability of the SK-
N-SH cells to differentiate into neuronal phenotype. 
Similarly to earlier reports (Lombet et al., 2001; Peng et 
al., 2015), we also observed morphological changes and 
elongation of neurites, induced by both RA- and RA/
PMA-treatment after 3 days, that were enhanced after 3 
more days (Fig. 1). While the PMA treatment activated 
cell differentiation, this effect was not as strong as in 
the case of the previously described procedures. In addi-
tion, after further incubation (3 days) a lower amount of 
cells was observed, suggesting an activation of apoptotic 
signals, which lead to degeneration of neurites and, in a 
consequence, to a decrease of the differentiation level. 
These morphological changes were in accordance with 
the calculated differentiation index for different studied 
models.
Moreover, the differentiation processes were also 
characterized by inhibition of cell proliferation. Our 
study on BrdU incorporation demonstrated a signifi-
cant inhibition of cell growth after differentiation treat-
ments (Fig. 2). Every differentiation type — with RA, 
PMA and a combination RA/PMA — inhibited the 
proliferation by 50%. These observations corroborated 
earlier studies, which showed diminished proliferation 
of neuroblastoma cells by both RA and PMA (Pizzi et 
al., 2002; Presgraves et al., 2004). Cells cultured in low 
Figure 7. Production of NO in SK-N-SH cells after differentiation. 
Cells after 80% confluence were differentiated with 5 µM RA or 
5 µM RA/25 nM PMA for 6 days. The NO concentration in medium 
from undifferentiated and differentiated cells (A) and the relative 
change in NO production after 2-hour stimulation with 10 µg/ml 
TNF-α in comparison to non-stimulated cells (B) was measured 
with fluorometric assay. *P<0.01 versus control sample (undifferen-
tiated cells).
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FBS medium without differentiation agents, presented a 
reduced proliferation rate but this decrease, contrary to 
earlier reports, was insignificant as compared to undif-
ferentiated cells cultured in a complete medium (Buttigli-
one et al., 2007). Similar results were obtained from the 
measurement of total protein concentration in samples 
after differentiation. Interestingly, the total concentration 
of protein for the sample treated with PMA was signifi-
cantly lower than for other differentiated samples. This 
observation, together with those from the analysis of 
cell morphology change, allowed to affirm that the PMA 
treatment caused inhibition of cell proliferation. Howev-
er, the significant decrease in protein concentration may 
be also associated with the activation of apoptotic pro-
cesses, due to the fact that neurite development in these 
cells was definitely lower and a cell detachment was also 
observed. Certainly, apoptotic effects have been reported 
in studies on cell differentiation with PMA (Takada et al., 
1999; Chornyy et al., 2007; Itsumi et al., 2014).
In fact, studies on the impact of differentiating fac-
tors on cell apoptosis confirmed these affirmations. The 
results showed that in cells treated with PMA, caspase 
3/7 activity increased almost twice (Fig. 3). Even sam-
ples differentiated with RA/PMA showed greater activity 
of this enzyme, although a little smaller than when PMA 
was only used. On the contrary, samples stimulated with 
RA presented similar values of this apoptosis marker to 
those obtained in control cells, both undifferentiated and 
cultured in low FBS medium. Therefore, we propose 
that PMA can certainly cause the cell differentiation but 
at the same time it can activate certain apoptosis path-
ways which can consequently lead to cell death. Signal-
ling pathways involved in these processes can be associ-
ated with protein kinase C. This enzyme is an important 
regulator of cell proliferation, malignant transformation 
as well as cell apoptosis (Gonzalez-Guerrico et al., 2005). 
In previous studies, protein kinase C activation in neuro-
blastoma cells by PMA but not by RA was demonstrated 
(Bouillon & Audette, 1993; Soderholm et al., 2001). Bear-
ing in mind these observations, it seems that the use of 
PMA as a differentiation agent of neuroblastoma cells 
may results in an inadequate cell model, especially con-
cerning the study of neurodegenerative processes.
Accordingly, following experiments were focused 
on RA- or RA/PMA-differentiated models, omitting 
the PMA-differentiated one, which was assumed to be 
strongly pro-apoptotic due to the large caspase 3/7 acti-
vation. At first, the expression of cancerous and neuronal 
markers after cell differentiation was compared with un-
differentiated cells. Our studies showed a decrease in the 
c-myc mRNA expression, suggesting inhibition of pro-
liferation of differentiated cells by both treatments (RA 
and RA/PMA). The c-myc is a known oncogene involved 
in tumor initiation, whose mRNA amplification in stud-
ies related to neuroblastoma therapy is recognized as a 
marker of poor prognosis (Grotzer et al., 2001). Due to 
intensive c-myc gene expression in the neuronal type of 
SK-N-SH cells, this oncogene was selected as a mark-
er of the tumor inhibition (Sadee et al., 1987). In addi-
tion, previous reports demonstrated that RA and PMA 
were able to inhibit the expression of this gene (Pahl-
man et al., 1991, Shi et al., 2010). In our study we also 
showed, that differentiating treatment, with RA alone or 
in combination with PMA, caused an essential decrease 
on c-myc mRNA in comparison to undifferentiated cells. 
However, a higher, significant effect was observed after 
RA treatment (Fig. 4A). These results support our ear-
lier assumption, that the RA-differentiation of SK-N-SH 
cell line seems to be more advantageous than the use of 
PMA. A similar conclusion can be based on the analy-
sis of the appearance of neuronal markers after differ-
entiation. Both treatments, with RA as well as with RA/
PMA were able to induce strong mRNA expression of 
neuronal markers, BDNF and NeuN as compared to un-
differentiated cells (Fig. 4B and 4C). These observations 
confirmed previous studies in which enhanced BDNF 
and NeuN expression was developed after differentia-
tion in several neuroblastoma cells (Palhman et al., 1995; 
Feng et al., 2001; Pizzi et al, 2002; Cheung et al., 2009; 
Agholme et al., 2010). However, we noticed a significant 
difference in the amount of BDNF mRNA in the stud-
ied models in favour of the RA-differentiation model, 
arguing for their superiority.
In the pathogenesis of several disorders involving 
nervous tissues, including neurodegenerative diseases, the 
chronic inflammation plays an important role (Khandel-
wal et al., 2011). Additionally, the development of chron-
ic inflammation is associated with impaired balance be-
tween production and degradation of cytokines. In this 
study, we checked the effect of differentiation agents on 
the production of the most important pro-inflammatory 
cytokines — TNF-α, IL-1β and IL-6 — by neuroblas-
toma cell line SK-N-SH. All analyzed cytokines were 
strongly up-regulated at gene expression level, and a po-
tent protein release by cells after RA/PMA treatment 
was observed, whereas the use of RA as the differentia-
tion factor caused a more attenuated effect that was in-
significant in terms of protein release (Fig 5). Studies on 
cytokine production after RA and PMA differentiation, 
performed in other types of cells, showed similar results. 
In experiments carried out on the murine macrophage 
cell line J774A.1, mRNA expression of TNF-α and IL-
1β was increased by RA, but this effect was not translat-
ed to protein release by cells (Mathew & Sharma, 2000). 
In turn, phorbol esters caused enhanced expression and 
translation of TNF-α in a human malignant histiocyto-
sis cell line. However, IL-1β protein could not be pro-
duced, suggesting a different pathway for the regulation 
of the synthesis of these cytokines (Gogusev et al., 1996). 
The most interesting results were associated with the 
study on the sensitivity of the differentiated cell models 
to induce inflammatory response after LPS stimulation 
(Fig. 6). We compared the cytokine release by SK-N-SH 
cells differentiated with RA or RA/PMA, obtaining un-
ambiguous results, which showed a stronger response of 
cells treated with RA to inflammatory stimuli. Perhaps 
this may be related to the anti-inflammatory effect attrib-
uted to RA (Bai et al., 2009; Gu et al., 2010), whereas 
PMA treatment is associated with a pro-inflammatory re-
sponse (Chiang et al., 2014; Zhang et al., 2013). In fact, 
a great production of pro-inflammatory cytokines was 
documented after LPS stimulation in others neuronal 
models. One of the most popular models is comprised 
by embryonic PC12 cells isolated from a pheochromo-
cytoma of rat adrenal medulla. These cells, after differ-
entiation with nerve growth factor, were able to release 
enormous amount of cytokines, such as TNF-α and IL-
1β after LPS treatment (Muchhala & Benzeroual, 2012; 
Yagnik & Benzeroual, 2013). Hence, we can assume that 
the large production of cytokines, reached by RA-differ-
entiated cells in response to LPS, argues for the high ef-
fectiveness of this differentiating agent as compared to 
phorbol esters in the preparation of suitable neuronal 
model. Therefore, these observations allow us to suggest 
once again the superiority of RA-treatment for differen-
tiation of SK-H-SN cells.
Inflammatory response is strictly associated with dis-
turbance of the oxidant-antioxidant balance. Abundant 
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increase of free radicals in cells initiates the inflammatory 
processes that lead to cell death. The production of nitric 
oxide radical — one of the most popular free radicals in-
volved in neurological disorders (Emerit et al., 2004) — 
was analyzed in order to prove the influence of RA and 
PMA on oxidative stress during differentiation processes. 
The results indicated a decreased production of NO by 
RA-treated cells, whereas the NO level in cells differenti-
ated with RA/PMA was similar to that in control cells 
(Fig. 7A). Earlier studies documented a similar effect of 
RA in J774A.1 cells, a murine macrophage cell line and 
in human neuroblastoma cell line SH-5YSY (Mathew & 
Sharma, 2000; Cheung et al., 2009). The opposite effect 
induced by PMA was also shown (Hortelano et al, 1992; 
Kawase et al. 1998). Moreover, a pro-oxidative effect of 
PMA in human fibrosarcoma cells, through the stimula-
tion of the production of reactive oxidative species, was 
proposed (Kim et al., 2013).
Therefore, our observations are in accordance with 
the studies above described. For this reason, the ability 
of differentiated cells to produce NO after TNF-α stim-
ulation was additionally studied. The PMA-treated cells 
showed no changes in NO production after stimulus, 
whereas cells differentiated with RA presented only an 
attenuated increase of NO release after TNF-α incuba-
tion for 2 hours (Fig. 7B). Despite the growing tendency 
in cytokine-induced NO release, observed in RA-differ-
entiated cells, these results did not present a significant 
difference from those from PMA-treated cells. Several 
studies performed with differentiated PC12 cells have 
showed an elevated NO concentration in medium af-
ter stimulation with LPS alone or in combination with 
TNF-α (Heneka et al., 1998; Ansari et al., 2011; Yagnik & 
Benzeroual, 2013). Moreover, an enhanced production of 
ROS or changes in the activity of anti-oxidative enzymes 
were also detected after stimulation of PC12 cells with 
cytokines (Khodagholi & Tussi, 2011; Chen et al., 2013). 
Taking into account these studies, we also expected a 
decisive increase of NO release by SK-N-SH cells after 
treatment with TNF-α, especially in RA-differentiated 
cells. Unfortunately, in our study we did not observe sig-
nificant changes in NO production. However, it should 
be noted that PMA differentiation of these cells resulted 
in a production of large amount of TNF-α, which may, 
in turn, activate pathways, causing an increased free rad-
ical production (e.g., NO) before an exogenous TNF-α 
stimulation. While the results obtained with PMA-treated 
cell can be explained in this way, the slight NO produc-
tion observed after TNF-α stimulation in RA-differenti-
ated cells is difficult to explicate. In this case, RA did 
not affect significantly the cytokine release. Additional 
studies on oxidative stress related to differentiation treat-
ments, e.g., including the analysis of different markers, 
could provide interesting conclusions.
Our results confirm that pathways of cell differentia-
tion may be of crucial importance for obtaining a neu-
ronal model and that RA allowed to achieve a more 
appropriate human cell model for inflammatory studies 
in neuroscience. It should be emphasized here, that the 
observations on differentiation level and the pro-inflam-
matory responses achieved in our studies cannot be at-
tributed to cell line heterogeneity. We performed exper-
iments with SK-N-SH cells including a high percentage 
of neuronal phenotype (greater than 95% as it was con-
firmed under microscopy observation). Hence, the de-
tected differences in studied models should be attributed 
to the effect of differentiation factors on cell functions, 
especially on the controlling of signaling pathways. In-
deed, Xie at al. (2010) described the influence of various 
differentiation agents on the SH-5YSY neuroblastoma 
cell line with the aim to obtain a cellular model of Par-
kinson’s disease, suggesting varied susceptibility of those 
models to neurotoxins. In conclusion, we demonstrated 
that RA-treated SK-N-SH cells may constitute an excel-
lent model to study inflammatory processes associated 
with disorders of nervous tissues, because cancer cells 
were able to transform into neuron-like cells, without 
apoptotic signals and exhibiting greater sensitivity to pro-
inflammatory stimuli.
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